ENRICH trial marks a likely new era in ICH management
New research sheds light on a potentially devastating condition that is reversible when properly managed
Digital subtraction angiography remains central to assessment of ‘benign’ PMSAH
Higher complete reperfusion rate seen with tenecteplase vs. alteplase in single-center study of stroke with LVO
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Times to target blood pressure, CT and medication administration shorter than with EMS transport
Target: Stroke yields more frequent and faster thrombolysis, but disparities remain for non-white population
Vigilant MRI evaluation needed for prompt care of potentially reversible inflammation, study finds
First-in-human trial demonstrates safety, encouraging functional response in chronic phases of recovery
IV thrombolysis should not be delayed because of planned thrombectomy
Case series demonstrates successful retreatment of this rare emergency